Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models
Douglas, C. R.; Lomeli, N.; Lepe, J.; Di, K.; Nandwana, N. K.; Vu, T.; Pham, J.; Kenney, M. C.; Das, B.; Bota, D.
Show abstract
Withdrawal StatementThe authors have withdrawn their manuscript owing to massive revision and data validation. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Advancing Clinical Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator Efficacy in Preclinical Models and Safety in Phase I Trials 96%
- Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma 96%
- High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma 95%
Similar papers in this journal
- Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity 96%
- Enhancing Intracellular Accumulation and Target Engagement of PROTACs with Reversible Covalent Chemistry 95%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 95%
Similar papers in this journal
- Rapid Resistance To Bet Inhibitors Is Mediated By Fgfr1 In Glioblastoma 97%
- Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A 94%
- Targeting the translational machinery in gastrointestinal stromal tumors (GIST) - a new therapeutic vulnerability 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.